• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铝佐剂 H5N1 全病毒灭活疫苗(WIV)增强了炎症细胞因子的产生。

Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) enhanced inflammatory cytokine productions.

机构信息

Kitasato Institute for Life Sciences, Laboratory of Viral Infection, Tokyo, Japan.

出版信息

Vaccine. 2012 Jun 6;30(26):3885-90. doi: 10.1016/j.vaccine.2012.04.004. Epub 2012 Apr 13.

DOI:10.1016/j.vaccine.2012.04.004
PMID:22507655
Abstract

Alum-adjuvanted H5 whole virion inactivated vaccine (WIV) was licensed for adults in Japan but induced marked febrile reactions with significantly stronger antibody responses in children. In this study, the mechanisms behind the different responses were investigated. Lymphocytes were obtained from 25 healthy subjects who were not immunized with H5 vaccine, to examine the innate immune impact of the various vaccine formulations, analyzing the cytokine production profile stimulated with alum adjuvant alone, alum-adjuvanted H5 WIIV, plain H5 WIV, and H5 split vaccine. Alum adjuvant did not induce cytokine production, but H5 split induced IFN-γ and TNF-α. H5 WIV induced IL-6, IL-17, TNF-α, MCP-1, IFN-γ, and IFN-α. An extremely low level of IL-1β was produced in response to H5 WIV, and alum-adjuvanted H5 WIV enhanced IL-1β production, with similar levels of other cytokines stimulated with H5 WIV. Enhanced production of cytokines induced by alum-adjuvanted H5 WIV may be related to the higher incidence of febrile reactions with stronger immune responses in children but it should be further investigated why efficient immune responses with febrile illness were observed only in young children.

摘要

日本已批准含佐剂的 H5 全病毒灭活疫苗(WIV)用于成年人,但该疫苗会引起明显的发热反应,且在儿童中产生的抗体反应更强。在这项研究中,研究了不同反应背后的机制。从 25 名未接种过 H5 疫苗的健康受试者中获得淋巴细胞,以研究各种疫苗制剂对固有免疫的影响,分析单独用铝佐剂、铝佐剂 H5 WIIV、普通 H5 WIV 和 H5 裂解疫苗刺激后的细胞因子产生谱。铝佐剂本身不会诱导细胞因子产生,但 H5 裂解会诱导 IFN-γ 和 TNF-α。H5 WIV 诱导产生 IL-6、IL-17、TNF-α、MCP-1、IFN-γ 和 IFN-α。H5 WIV 仅引起极低水平的 IL-1β 产生,而铝佐剂 H5 WIV 增强了 IL-1β 的产生,与用 H5 WIV 刺激产生的其他细胞因子水平相似。铝佐剂 H5 WIV 诱导的细胞因子产生增强可能与儿童发热反应发生率更高和更强的免疫反应有关,但仍需进一步研究为何仅在幼儿中观察到发热性疾病的有效免疫反应。

相似文献

1
Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) enhanced inflammatory cytokine productions.铝佐剂 H5N1 全病毒灭活疫苗(WIV)增强了炎症细胞因子的产生。
Vaccine. 2012 Jun 6;30(26):3885-90. doi: 10.1016/j.vaccine.2012.04.004. Epub 2012 Apr 13.
2
Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) induced IgG1 and IgG4 antibody responses in young children.铝佐剂 H5N1 全病毒灭活疫苗(WIV)可诱导幼儿产生 IgG1 和 IgG4 抗体应答。
Vaccine. 2012 Dec 14;30(52):7662-6. doi: 10.1016/j.vaccine.2012.10.006. Epub 2012 Oct 24.
3
Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults.甲型H5N1流感原型佐剂灭活裂解病毒疫苗在健康成年人中安全性和免疫原性的I期和II期随机试验。
Vaccine. 2008 Aug 5;26(33):4160-7. doi: 10.1016/j.vaccine.2008.05.077. Epub 2008 Jun 13.
4
Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial.佐剂灭活分节段和全病毒流感 A(H5N1)疫苗在儿童中的安全性和免疫原性:一项 I- II 期随机试验。
Vaccine. 2010 Aug 31;28(38):6221-7. doi: 10.1016/j.vaccine.2010.07.008. Epub 2010 Jul 16.
5
Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.明矾可增强小鼠对全灭活病毒流感疫苗的TH2型抗体反应,但不能提供更好的保护。
Vaccine. 2008 May 2;26(19):2350-9. doi: 10.1016/j.vaccine.2008.02.063. Epub 2008 Mar 18.
6
Superior protection provided by a single dose of MF59-adjuvanted whole inactivated H5N1 influenza vaccine in type 1 diabetic mice.MF59 佐剂全灭活 H5N1 流感疫苗在 1 型糖尿病小鼠中提供的优越保护。
Arch Virol. 2011 Mar;156(3):387-95. doi: 10.1007/s00705-010-0860-4. Epub 2010 Nov 26.
7
A prime-boost vaccination of mice with heterologous H5N1 strains.用异源H5N1毒株对小鼠进行初免-加强免疫接种。
Vaccine. 2009 May 18;27(23):3121-5. doi: 10.1016/j.vaccine.2009.01.007.
8
Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.一种灭活的、含佐剂的大流行性流感(H5N1)原型疫苗的免疫原性、安全性及交叉反应性:一项II期双盲随机试验
Clin Infect Dis. 2009 Apr 15;48(8):1087-95. doi: 10.1086/597401.
9
The Madin-Darby canine kidney cell culture derived influenza A/H5N1 vaccine: a phase I trial in Taiwan.源自马-达二氏犬肾细胞的流感 A/H5N1 疫苗:台湾的 I 期临床试验。
J Microbiol Immunol Infect. 2013 Dec;46(6):448-55. doi: 10.1016/j.jmii.2012.08.002. Epub 2012 Sep 27.
10
Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.一种原型佐剂灭活裂解甲型流感(H5N1)疫苗在婴幼儿中的安全性和免疫原性。
Vaccine. 2008 Nov 25;26(50):6383-91. doi: 10.1016/j.vaccine.2008.08.046. Epub 2008 Sep 16.

引用本文的文献

1
Developmental Immunotoxicity, Perinatal Programming, and Noncommunicable Diseases: Focus on Human Studies.发育免疫毒性、围产期编程与非传染性疾病:聚焦人类研究
Adv Med. 2014;2014:867805. doi: 10.1155/2014/867805. Epub 2014 Jan 23.
2
Production of inflammatory cytokines in response to diphtheria-pertussis-tetanus (DPT), haemophilus influenzae type b (Hib), and 7-valent pneumococcal (PCV7) vaccines.白喉-百日咳-破伤风(DPT)疫苗、b型流感嗜血杆菌(Hib)疫苗和7价肺炎球菌(PCV7)疫苗接种后炎症细胞因子的产生。
Hum Vaccin Immunother. 2014;10(3):677-85. doi: 10.4161/hv.27264. Epub 2013 Dec 3.
3
Vaccine chronicle in Japan.
日本疫苗大事记。
J Infect Chemother. 2013 Oct;19(5):787-98. doi: 10.1007/s10156-013-0641-6. Epub 2013 Jul 9.